TV2 Holding Co
Funding rounds
7 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Nov 2013 | $2 M | No. 7 | Under $2 million | options | SEC | |
| Nov 2013 | $40 M | No. 6 | $10 to $50 million | equity | SEC | |
| Jun 2012 | $35 M | No. 5 | $10 to $50 million | equity | SEC | |
| Apr 2012 | $4 M | No. 4 | $2 to $10 million | debt, options | SEC | |
| Feb 2012 | $7 M | No. 3 | $2 to $10 million | debt, options | SEC | |
| Jun 2010 | $45 M | No. 2 | $10 to $50 million | equity, options | SEC | |
| Nov 2009 | $31 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
TV2 Holding Co chose not to state its revenue in its newest notice of a funding round (Dec 2013).
SEC Form D · Dec 2013
The industry group it chose in its notices: Other Health Care.
SEC Form D · Dec 2013
That is all the official record says: TV2 Holding Co has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
21 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Deerfield Management Company, L.P. | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Deerfield Mgmt L.P. | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Deerfield Private Design Fund II, L.P. | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Deerfield Private Design International II, Ltd. | Company | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Deerfield Special Situations Fund, L.P. | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Deerfield Special Situations International Master Fund, L.P. | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Delphi BioInvestments VIII LP | Fund or asset manager | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Delphi Bioinvestments VII LP | Fund or asset manager | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Delphi Management Partners VIII, L.L.C. | Fund or asset manager | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Delphi Management Partners VII, L.L.C. | Fund or asset manager | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Delphi Ventures VIII LP | Venture capital | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Delphi Ventures VII L.P. | Venture capital | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| MPM Asset Management Investors BV4 LLC | Fund or asset manager | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| MPM BioVentures IV GmbH & Co. Beteiligungs KG | Venture capital | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| MPM BioVentures IV GP LLC | Venture capital | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| MPM BioVentures IV LLC | Venture capital | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| MPM BioVentures IV QP LP | Venture capital | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Nea 12 GP, LLC | Other | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| NEA Partners 12, Limited Partnership | Fund or asset manager | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| New Enterprise Associates 12, Limited Partnership | Fund or asset manager | not stated | not stated | Held Series A, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Robert Thomas | Person | not stated | not stated | Held Series B, C, D and E preferred stock, director (Form 3, 2014) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 34 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Kimberley Elting | Executive officer | Dec 2013 |
| Louis J. Molinari | Executive officer | Dec 2013 |
| Michael Chobotov | Executive officer | Dec 2013 |
| Michael Kramer | Executive officer | Dec 2013 |
| Robert G. Whirley | Executive officer | Dec 2013 |
| Shari L. O'Quinn | Executive officer | Dec 2013 |
| Vivek K. Jayaraman | Executive officer | Dec 2013 |
| Christopher Chavez | Executive officer | Nov 2013 |
| Kimberley E. Elting | Executive officer | Nov 2013 |
| Christopher V. Chavez | Executive officer | May 2012 |
| Robert V. Thomas | Executive officer | May 2012 |
| Robert Thomas | Executive officer | Feb 2012 |
| Joseph Humphrey | Executive officer | Jul 2010 |
| Lou Molinari | Executive officer | Jul 2010 |
| Robert Whirley | Executive officer | Jul 2010 |
| Shari Allen | Executive officer | Jul 2010 |
| Steven Harrison | Executive officer | Jul 2010 |
| Stuart Kaler | Executive officer | Jul 2010 |
| Vivek Jayaraman | Executive officer | Jul 2010 |
| Arun Ramamoorthy | Director | Dec 2013 |
| Douglas Roeder | Director | Dec 2013 |
| Jake Nunn | Director | Dec 2013 |
| James Scopa | Director | Dec 2013 |
| James Shapiro | Director | Dec 2013 |
| Michael Chobotov | Director | Dec 2013 |
| Robert Thomas | Director | Dec 2013 |
| Ryan Drant | Director | Dec 2013 |
| Arun E. Ramamoorthy | Director | Nov 2013 |
| Christopher Chavez | Director | Nov 2013 |
| Daniel Moore | Director | Nov 2013 |
| Samuel E. Brasch | Director | Nov 2013 |
| David Kim | Director | Jun 2012 |
| Christopher V. Chavez | Director | May 2012 |
| Daniel V. Moore | Director | May 2012 |
| David V. Kim | Director | May 2012 |
| Douglas V. Roeder | Director | May 2012 |
| Jake V. Nunn | Director | May 2012 |
| James V. Scopa | Director | May 2012 |
| James V. Shapiro | Director | May 2012 |
| Michael V. Chobotov | Director | May 2012 |